Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Translocase of inner mitochondrial membrane 9 (TIMM9) is a mitochondrial intermembrane space chaperone protein. It is a highly conserved component of the inner mitochondrial membrane's protein import machinery, forming a hexameric complex with TIMM10 to escort hydrophobic precursor proteins to the mitochondrial inner membrane and protect them from aggregation. TIMM9 is essential for the biogenesis of various multi-pass membrane proteins, functioning as part of carrier import pathways, most notably with the TIM22 complex for metabolite carrier insertion and the sorting and assembly machinery (SAM) for outer membrane proteins[1][2][3][5]. Recent research also implicates TIMM9 as a clinically relevant biomarker associated with progression and prognosis in several cancers, such as gastric cancer; its disruption impairs mitochondrial function, cell metabolism, and cell viability[1][4][5]. No approved or investigational drugs specifically target TIMM9, and its essential role in mitochondrial protein import means it is not currently considered a conventional therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Translocase of inner mitochondrial membrane 9 (TIMM9).